Sun Pharma moves up on USFDA approval for generic Temodar - The New Indian Express

Sun Pharma moves up on USFDA approval for generic Temodar

Published: 14th February 2014 11:19 AM

Last Updated: 14th February 2014 11:19 AM

Sun Pharmaceutical Industries sharesgained after the US FDA has granted its subsidiary final approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Temodar, Temozolomide Capsules, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg.

Temozolomide Capsules, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg are therapeutic equivalents of Merck Sharp & Dohme Corporation's Temodar Capsules.

Shares of the company are trading at Rs 622.30, up Rs 7.6, or 1.24% at the Bombay Stock Exchange (BSE) on Friday at 10:07 a.m.The scrip has touched an intra-day high of Rs 626.25 and low of Rs 619.10. The total volume of shares traded at the BSE is 71,518.In the earlier session, the shares climbed 0.6%, or Rs 3.65, at Rs 614.70.Currently, the stock is trading down 4.26% from its 52-week high of Rs 650.00 and above 61.57% over the 52-week low of Rs 385.15.

comments powered by Disqus

Disclaimer: We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the NIE editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.


follow us Mobile Site iPad News Hunt Android RSS Tumblr Linekin Pinterest Youtube Google Plus Twitter Facebook